Description
Recombinant monoclonal antibody to GM3/GM4 terminal ganglioside sugars. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma L612.
Target
GM3/GM4 terminal ganglioside sugars
Target Alias Names
NeuAc α2-3 Galactose, NeuAc alpha 2-3 Galactose
Isotype/Mimetic
IgM
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Methods
Naïve display libraries derived from human B cells, or naïve display libraries from animal B cells or Display libraries from synthetic or natural framework sequences
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-free discovery, Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression